Who Paid My Doc Search
Menu
Organisation paid for research Program year 2025 Source: CMS Open Payments

Andover Eye Associates

Neither a doctor nor a teaching hospital

Research payments

$3,213,871

115 payments

Through program year 2025, Andover Eye Associates is reported as receiving $3,213,871 in research payments, across 115 payments.

By program year

7 rows
Year Kind Amount Payments
2025 Research $855,010 11
2024 Research $6,248 2
2023 Research $1,080,617 25
2022 Research $209,859 22
2021 Research $454,469 24
2020 Research $333,966 19
2019 Research $273,702 12

Breakdown

Who paid Research payments · program years 2019–2025
  1. Bausch & Lomb Americas Inc. $1,480,491 31 payments
  2. Vanda Pharmaceuticals Inc. $625,670 8 payments
  3. Novartis Pharmaceuticals Corporation $284,065 7 payments
  4. Kowa Research Institute, Inc. $267,190 10 payments
  5. Regeneron Pharmaceuticals, Inc. $188,727 10 payments
  6. Nidek Co., Ltd. $172,071 9 payments
  7. Alcon Research LLC $125,933 14 payments
  8. Aerie Pharmaceuticals, Inc. $53,800 19 payments
  9. Oyster Point Pharma, Inc. $15,924 7 payments
Studies the money was for Research payments · program years 2019–2025
  1. A Multi-Center, Double-Masked, Randomized, Vehicle-Controlled, Parallel-Group Study Evaluating the Safety and Pharmacokinetics of Brimonidine Tartrate 0.025%/Ketotifen Fumarate 0.035% Combination Ophthalmic Solution, Used Two Times Daily in Healthy $633,321 11 payments
  2. A Randomized, Multicenter, Double-Masked, Active-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of Brimonidine Tartrate Ophthalmic Solution 0.025% With Sodium Hyaluronate Relative to Lumify in Adult Subjects With Ocular Redness $428,650 3 payments
  3. A Four-Week, Double-Masked, Randomized, Placebo-Controlled, Phase 2, Evaluation of the Safety and Efficacy of VSJ-110 Ophthalmic Solution in the Treatment of Dry Eye $377,570 3 payments
  4. A Prospective Study to Evaluate the Clinical Characteristics and Disease Progression of Patients With Meibomian Gland Dysfunction (MGD) $284,065 7 payments
  5. A Multi-Center, Double-Masked, Randomized, Parallel-Group, Vehicle-Controlled Evaluation of the Onset and Duration of Action of the Combination Drug Product Brimonidine Tartrate 0.025%/Ketotifen Fumarate 0.035% Ophthalmic Solution Compared to its Components and Vehicle for the Treatment of Allergic Conjunctivitis in the Conjunctival Allergen Challenge Model $270,551 6 payments
  6. Safety and Efficacy of Vsj-110 in the Treatment of Allergic Conjunctivitis in Adults With A History of Ocular Allergies $248,100 5 payments
  7. A Study to Evaluate the Efficacy of Dupilumab As An Adjunct for Subcutaneous Grass Immunotherapy to Reduce Provoked Allergic Rhinitis Symptoms Using the Nasal Allergen Challenge Model $188,727 10 payments
  8. K-161-201 $182,215 8 payments
  9. Agreement and Precision Study of the Nidek Mirante OCT Compared to the Optovue RTVue XR Avanti OCT and SLO Image Comparison of the Nidek Mirante and the OPTOS P200DTx $172,071 9 payments
  10. K-161-201 $84,975 2 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record